Characteristics of the First 102 Severe COVID-19 Cases Treated With Convalescent Plasma or Tocilizumab or Both in Al-Nahdha Hospital, Oman

BACKGROUND: In the absence of an effective vaccine, the coronavirus disease (COVID-19) continues to cause more deaths. Evidence on the effectiveness of various COVID-19 management plans is inconclusive. This paper describes the characteristics of the first 102 severe COVID-19 in-patients treated wit...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Health Serv Res Manag Epidemiol
Main Authors: Al Harthi, Saud, Osali, Magdi Al, Kindi, Nasser Al, Kharusi, Zahir Al, Qasabi, Salim Al, Hinai, Mohamed Al, Ghafri, Thamra Al
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publications 2021
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7878948/
https://ncbi.nlm.nih.gov/pubmed/33623809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2333392820986639
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki